Cartilage tissue engineering: Molecular control of chondrocyte differentiation for proper cartilage matrix reconstruction

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 8, 2014, Pages 2414-2440

  Demoor, Magali ^a   Ollitrault, David ^a   Gomez Leduc, Tangni ^a   Bouyoucef, Mouloud ^a   Hervieu, Magalie ^a   Fabre, Hugo ^b   Lafont, Jérôme ^b   Denoix, Jean Marie ^c   Audigié, Fabrice ^c   Mallein Gerin, Frédéric ^b   Legendre, Florence ^a   Galera, Philippe ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b CNRS UMR 5305   (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

Cartilage; Cell therapy; Chondrocyte; Mesenchymal stem cell; Osteoarthritis; Tissue engineering

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; COLLAGEN TYPE 2; HOMEODOMAIN PROTEIN; HTRA1 PROTEIN; LIOTHYRONINE; MICRORNA; NK3 HOMEOBOX 2; PARATHYROID HORMONE RELATED PROTEIN; PROTEINASE; SOMATOMEDIN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SOX5; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 219;

AGING; ALTERNATIVE RNA SPLICING; ANTERIOR CRUCIATE LIGAMENT INJURY; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOSYNTHESIS; BONE DEVELOPMENT; CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CATABOLISM; CELL DEDIFFERENTIATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL THERAPY; CHONDROGENESIS; COCULTURE; EXTRACELLULAR MATRIX; GENE THERAPY; HOMEOSTASIS; HUMAN; HYPERTROPHY; IN VITRO STUDY; MECHANICAL STIMULATION; MESENCHYMAL STEM CELL; MOLECULAR PATHOLOGY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN FUNCTION; REVIEW; RISK FACTOR; TISSUE ENGINEERING; TRANSCRIPTION REGULATION;

CARTILAGE; CELL THERAPY; CHONDROCYTE; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; TISSUE ENGINEERING;

ANIMALS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CHONDROCYTES; CHONDROGENESIS; EXTRACELLULAR MATRIX; HUMANS; TISSUE ENGINEERING;

EID: 84903393809     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2014.02.030     Document Type: Review

References (398)

1. L.C. Tetlow, D.J. Adlam, and D.E. Woolley Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes Arthritis Rheum. 44 2001 585 594
2. K.M. Clements, J.K. Flannelly, J. Tart, S.M.V. Brockbank, J. Wardale, and J. Freeth et al. Matrix metalloproteinase 17 is necessary for cartilage aggrecan degradation in an inflammatory environment Ann. Rheum. Dis. 70 2011 683 689
3. R.F. Loeser Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix Osteoarthr. Cartil. 17 2009 971 979
4. A.A. Young, M.M. Smith, S.M. Smith, M.A. Cake, P. Ghosh, and R.A. Read et al. Regional assessment of articular cartilage gene expression and small proteoglycan metabolism in an animal model of osteoarthritis Arthritis Res. Ther. 7 2005 R852 R861
5. M. Brittberg, A. Lindahl, A. Nilsson, C. Ohlsson, O. Isaksson, and L. Peterson Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation N. Engl. J. Med. 331 1994 889 895
6. E.B. Hunziker, T.M. Quinn, and H.-J. Häuselmann Quantitative structural organizationof normal adult human articular cartilage Osteoarthr. Cartil. 10 2002 564 572
7. M.E. Nuttall, D.P. Nadeau, P.W. Fisher, F. Wang, P.M. Keller, and W.E. DeWolf et al. Inhibition of caspase-3-like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro J. Orthop. Res. 18 2000 356 363
8. C.A. Poole Articular cartilage chondrons: form, function and failure J. Anat. 191 Pt 1 1997 1 13
9. S. Hattori, C. Oxford, and A.H. Reddi Identification of superficial zone articular chondrocyte stem/progenitor cells Biochem. Biophys. Res. Commun. 358 2007 99 103
10. S. Alsalameh, R. Amin, T. Gemba, and M. Lotz Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage Arthritis Rheum. 50 2004 1522 1532
11. M. Bernfield, R. Kokenyesi, M. Kato, M.T. Hinkes, J. Spring, and R.L. Gallo et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans Annu. Rev. Cell Biol. 8 1992 365 393
12. J. Mollenhauer, J.A. Bee, M.A. Lizarbe, and K. von der Mark Role of anchorin CII, a 31,000-mol-wt membrane protein, in the interaction of chondrocytes with type II collagen J. Cell Biol. 98 1984 1572 1579
13. J. Dürr, S. Goodman, A. Potocnik, H. von der Mark, and K. von der Mark Localization of beta 1-integrins in human cartilage and their role in chondrocyte adhesion to collagen and fibronectin Exp. Cell Res. 207 1993 235 244
14. T. Aigner, and J. Stöve Collagens - major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair Adv. Drug Deliv. Rev. 55 2003 1569 1593
15. S.W. Li, D.J. Prockop, H. Helminen, R. Fässler, T. Lapveteläinen, and K. Kiraly et al. Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone Genes Dev. 9 1995 2821 2830
16. J.M. Lane, C.T. Brighton, and B.J. Menkowitz Anaerobic and aerobic metabolism in articular cartilage J. Rheumatol. 4 1977 334 342
17. A. Mobasheri, S.J. Vannucci, C.A. Bondy, S.D. Carter, J.F. Innes, and M.F. Arteaga et al. Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis Histol. Histopathol. 17 2002 1239 1267
18. B.V. Shlopov, W.R. Lie, C.L. Mainardi, A.A. Cole, S. Chubinskaya, and K.A. Hasty Osteoarthritic lesions: involvement of three different collagenases Arthritis Rheum. 40 1997 2065 2074
19. C.R. Flannery, C.B. Little, C.E. Hughes, and B. Caterson Expression and activity of articular cartilage hyaluronidases Biochem. Biophys. Res. Commun. 251 1998 824 829
20. D.J. Buttle, A. Fowles, M.Z. Ilic, and C.J. Handley " Aggrecanase" activity is implicated in tumour necrosis factor alpha mediated cartilage aggrecan breakdown but is not detected by an in vitro assay, MP Mol. Pathol. 50 1997 153 159
21. T.M. Hering Regulation of chondrocyte gene expression Front. Biosci. 4 1999 D743 D761
22. V. Lefebvre, R.R. Behringer, and B. de Crombrugghe L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway Osteoarthr. Cartil. 9 Suppl. A 2001 S69 S75
23. V. Lefebvre, P. Li, and B. de Crombrugghe A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene EMBO J. 17 1998 5718 5733
24. P. Smits, P. Li, J. Mandel, Z. Zhang, J.M. Deng, and R.R. Behringer et al. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation Dev. Cell 1 2001 277 290
25. R.L. Widom, I. Culic, J.Y. Lee, and J.H. Korn Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression Gene 198 1997 407 420
26. P. Galéra, M. Musso, P. Ducy, and G. Karsenty c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin Proc. Natl. Acad. Sci. U. S. A. 91 1994 9372 9376
27. C. Ghayor, J.F. Herrouin, C. Chadjichristos, L. Ala-Kokko, M. Takigawa, and J.-P. Pujol et al. Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration J. Biol. Chem. 275 2000 27421 27438
28. E. Renard, B. Porée, C. Chadjichristos, M. Kypriotou, L. Maneix, and N. Bigot et al. Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes J. Mol. Med. (Berl) 90 2012 649 666
29. S.B. Kennett, A.J. Udvadia, and J.M. Horowitz Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription Nucleic Acids Res. 25 1997 3110 3117
30. G. Hagen, S. Müller, M. Beato, and G. Suske Sp1-mediated transcriptional activation is repressed by Sp3 EMBO J. 13 1994 3843 3851
31. B. Porée, M. Kypriotou, C. Chadjichristos, G. Beauchef, E. Renard, and F. Legendre et al. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter J. Biol. Chem. 283 2008 4850 4865
32. C. Chadjichristos, C. Ghayor, M. Kypriotou, G. Martin, E. Renard, and L. Ala-Kokko et al. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes J. Biol. Chem. 278 2003 39762 39772
33. L. Maneix, A. Servent, B. Porée, D. Ollitrault, N. Bigot, N. Boujrad et al., Up-regulation of type II collagen gene by 17β-estradiol in articular chondrocytes involves Sp1/3, Sox-9 and estrogen receptor alpha, J Mol Med (Berl). (submitted for publication).
34. Z.-G. Yu, N. Xu, W.-B. Wang, S.-H. Pan, K.-S. Li, and J.-K. Liu Interleukin-1 inhibits Sox9 and collagen type II expression via nuclear factor-kappaB in the cultured human intervertebral disc cells Chin. Med. J. 122 2009 2483 2488
35. F. Legendre, D. Ollitrault, M. Hervieu, C. Baugé, L. Maneix, and D. Goux et al. Enhanced hyaline cartilage matrix synthesis in collagen sponge scaffolds by using siRNA to stabilize chondrocytes phenotype cultured with BMP-2 under hypoxia Tissue Eng. C Methods 19 2013 550 567
36. T. Furumatsu, M. Tsuda, N. Taniguchi, Y. Tajima, and H. Asahara Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment J. Biol. Chem. 280 2005 8343 8350
37. T. Furumatsu, C. Shukunami, M. Amemiya-Kudo, H. Shimano, and T. Ozaki Scleraxis and E47 cooperatively regulate the Sox9-dependent transcription Int. J. Biochem. Cell Biol. 42 2010 148 156
38. T. Hattori, F. Coustry, S. Stephens, H. Eberspaecher, M. Takigawa, and H. Yasuda et al. Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5 Nucleic Acids Res. 36 2008 3011 3024
39. W. Huang, N. Lu, H. Eberspaecher, and B. de Crombrugghe A new long form of c-Maf cooperates with Sox9 to activate the type II collagen gene J. Biol. Chem. 277 2002 50668 50675
40. M.C. Ryan, and L.J. Sandell Differential expression of a cysteine-rich domain in the amino-terminal propeptide of type II (cartilage) procollagen by alternative splicing of mRNA J. Biol. Chem. 265 1990 10334 10339
41. L.J. Sandell, A.M. Nalin, and R.A. Reife Alternative splice form of type II procollagen mRNA (IIA) is predominant in skeletal precursors and non-cartilaginous tissues during early mouse development Dev. Dyn. 199 1994 129 140
42. Y. Zhu, A. Oganesian, D.R. Keene, and L.J. Sandell Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2 J. Cell Biol. 144 1999 1069 1080
43. U. Valcourt, J. Gouttenoire, E. Aubert-Foucher, D. Herbage, and F. Mallein-Gerin Alternative splicing of type II procollagen pre-mRNA in chondrocytes is oppositely regulated by BMP-2 and TGF-beta1 FEBS Lett. 545 2003 115 119
44. A. McAlinden, B. Johnstone, J. Kollar, N. Kazmi, and T.M. Hering Expression of two novel alternatively spliced COL2A1 isoforms during chondrocyte differentiation Matrix Biol. 27 2008 254 266
45. E. Aubert-Foucher, N. Mayer, M. Pasdeloup, A. Pagnon, D. Hartmann, and F. Mallein-Gerin A unique tool to selectively detect the chondrogenic IIB form of human type II procollagen protein Matrix Biol. 2013 10.1016/j.matbio.2013.09.001 pii: S0945-053X(13)00124-8
46. A.M. DeLise, L. Fischer, and R.S. Tuan Cellular interactions and signaling in cartilage development Osteoarthr. Cartil. 8 2000 309 334
47. C.W. Archer, and P. Francis-West The chondrocyte Int. J. Biochem. Cell Biol. 35 2003 401 404
48. A.R. Haas, and R.S. Tuan Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function Differentiation 64 1999 77 89
49. F. Burdan, J. Szumiło, A. Korobowicz, R. Farooquee, S. Patel, and A. Patel et al. Morphology and physiology of the epiphyseal growth plate Folia Histochem. Cytobiol. 47 2009 5 16
50. J. Chimal-Monroy, and L. Díaz de León Expression of N-cadherin, N-CAM, fibronectin and tenascin is stimulated by TGF-beta1, beta2, beta3 and beta5 during the formation of precartilage condensations Int. J. Dev. Biol. 43 1999 59 67
51. H. Akiyama, M.-C. Chaboissier, J.F. Martin, A. Schedl, and B. de Crombrugghe The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6 Genes Dev. 16 2002 2813 2828
52. T. Ikeda, S. Kamekura, A. Mabuchi, I. Kou, S. Seki, and T. Takato et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage Arthritis Rheum. 50 2004 3561 3573
53. J. Alvarez, M. Balbín, M. Fernández, and J.M. López Collagen metabolism is markedly altered in the hypertrophic cartilage of growth plates from rats with growth impairment secondary to chronic renal failure J. Bone Miner. Res. 16 2001 511 524
54. E. Zelzer, D.J. Glotzer, C. Hartmann, D. Thomas, N. Fukai, and S. Soker et al. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2 Mech. Dev. 106 2001 97 106
55. F. Djouad, B. Delorme, M. Maurice, C. Bony, F. Apparailly, and P. Louis-Plence et al. Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes Arthritis Res. Ther. 9 2007 R33
56. S. Kornfeld Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors Annu. Rev. Biochem. 61 1992 307 330
57. N.L. Schlechter, S.M. Russell, E.M. Spencer, and C.S. Nicoll Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin Proc. Natl. Acad. Sci. U. S. A. 83 1986 7932 7934
58. J.J. Van Wyk, and E.P. Smith Insulin-like growth factors and skeletal growth: possibilities for therapeutic interventions J. Clin. Endocrinol. Metab. 84 1999 4349 4354
59. M. Zhang, Q. Zhou, Q.-Q. Liang, C.-G. Li, J.D. Holz, and D. Tang et al. IGF-1 regulation of type II collagen and MMP-13 expression in rat endplate chondrocytes via distinct signaling pathways Osteoarthr. Cartil. 17 2009 100 106
60. C. Phornphutkul, K.-Y. Wu, X. Yang, Q. Chen, and P.A. Gruppuso Insulin-like growth factor-I signaling is modified during chondrocyte differentiation J. Endocrinol. 183 2004 477 486
61. L. O'Rear, L. Longobardi, M. Torello, B.K. Law, H.L. Moses, and F. Chiarelli et al. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth J. Mol. Endocrinol. 34 2005 723 737
62. C. An, Y. Cheng, Q. Yuan, and J. Li IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocytes-like cells Ann. Biomed. Eng. 38 2010 1647 1654
63. C. Seifarth, C. Csaki, and M. Shakibaei Anabolic actions of IGF-I and TGF-beta1 on Interleukin-1beta-treated human articular chondrocytes: evaluation in two and three dimensional cultures Histol. Histopathol. 24 2009 1245 1262
64. E. Grimaud, D. Heymann, and F. Rédini Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders Cytokine Growth Factor Rev. 13 2002 241 257
65. M. Enomoto-Iwamoto, M. Iwamoto, Y. Mukudai, Y. Kawakami, T. Nohno, and Y. Higuchi et al. Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes J. Cell Biol. 140 1998 409 418
66. H.A. Pedrozo, Z. Schwartz, R. Gomez, A. Ornoy, W. Xin-Sheng, and S.L. Dallas et al. Growth plate chondrocytes store latent transforming growth factor (TGF)-beta 1 in their matrix through latent TGF-beta 1 binding protein-1 J. Cell. Physiol. 177 1998 343 354
67. K. Karamboulas, H.J. Dranse, and T.M. Underhill Regulation of BMP-dependent chondrogenesis in early limb mesenchyme by TGFbeta signals J. Cell Sci. 123 2010 2068 2076
68. B. Keller, T. Yang, Y. Chen, E. Munivez, T. Bertin, and B. Zabel et al. Interaction of TGFβ and BMP signaling pathways during chondrogenesis PLoS ONE 6 2011 e16421
69. J.J. Song, R. Aswad, R.A. Kanaan, M.C. Rico, T.A. Owen, and M.F. Barbe et al. Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation J. Cell. Physiol. 210 2007 398 410
70. P.M. van der Kraan, E.N. Blaney Davidson, A. Blom, and W.B. van den Berg TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads Osteoarthr. Cartil. 17 2009 1539 1545
71. J. Gouttenoire, C. Bougault, E. Aubert-Foucher, E. Perrier, M.-C. Ronzière, and L. Sandell et al. BMP-2 and TGF-beta1 differentially control expression of type II procollagen and alpha 10 and alpha 11 integrins in mouse chondrocytes Eur. J. Cell Biol. 89 2010 307 314
72. T. Furumatsu, T. Ozaki, and H. Asahara Smad3 activates the Sox9-dependent transcription on chromatin Int. J. Biochem. Cell Biol. 41 2009 1198 1204
73. W.S. Toh, H. Liu, B.C. Heng, A.J. Rufaihah, C.P. Ye, and T. Cao Combined effects of TGFbeta1 and BMP2 in serum-free chondrogenic differentiation of mesenchymal stem cells induced hyaline-like cartilage formation Growth Factors 23 2005 313 321
74. A.T. Mehlhorn, P. Niemeyer, K. Kaschte, L. Muller, G. Finkenzeller, and D. Hartl et al. Differential effects of BMP-2 and TGF-beta1 on chondrogenic differentiation of adipose derived stem cells Cell Prolif. 40 2007 809 823
75. T.-F. Li, R.J. O'Keefe, and D. Chen TGF-beta signaling in chondrocytes Front. Biosci. 10 2005 681 688
76. X. Zhang, N. Ziran, J.J. Goater, E.M. Schwarz, J.E. Puzas, and R.N. Rosier et al. Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation Bone 34 2004 809 817
77. Y. Wang, R.M. Belflower, Y.-F. Dong, E.M. Schwarz, R.J. O'Keefe, and H. Drissi Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis J. Bone Miner. Res. 20 2005 1624 1636
78. C.M. Ferguson, E.M. Schwarz, P.R. Reynolds, J.E. Puzas, R.N. Rosier, and R.J. O'Keefe Smad2 and 3 mediate transforming growth factor-beta1-induced inhibition of chondrocyte maturation Endocrinology 141 2000 4728 4735
79. T. Alliston, L. Choy, P. Ducy, G. Karsenty, and R. Derynck TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation EMBO J. 20 2001 2254 2272
80. S. Zhou TGF-β regulates β-catenin signaling and osteoblast differentiation in human mesenchymal stem cells J. Cell. Biochem. 112 2011 1651 1660
81. S. Chubinskaya, M. Hurtig, and D.C. Rueger OP-1/BMP-7 in cartilage repair Int. Orthop. 31 2007 773 781
82. N.D. Miljkovic, G.M. Cooper, and K.G. Marra Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells Osteoarthr. Cartil. 16 2008 1121 1130
83. R.S. Tuan Cellular signaling in developmental chondrogenesis: N-cadherin, Wnts, and BMP-2 J. Bone Joint Surg. Am. 85-A Suppl. 2 2003 137 141
84. V. Rosen, J. Nove, J.J. Song, R.S. Thies, K. Cox, and J.M. Wozney Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes J. Bone Miner. Res. 9 1994 1759 1768
85. W.S. Toh, Z. Yang, B.C. Heng, and T. Cao Differentiation of human embryonic stem cells toward the chondrogenic lineage Methods Mol. Biol. 407 2007 333 349
86. Y. Wei, Y. Hu, R. Lv, and D. Li Regulation of adipose-derived adult stem cells differentiating into chondrocytes with the use of rhBMP-2 Cytotherapy 8 2006 570 579
87. B.K. Zehentner, C. Dony, and H. Burtscher The transcription factor Sox9 is involved in BMP-2 signaling J. Bone Miner. Res. 14 1999 1734 1741
88. H. Uusitalo, A. Hiltunen, M. Ahonen, T.J. Gao, V. Lefebvre, and V. Harley et al. Accelerated up-regulation of L-Sox5, Sox6, and Sox9 by BMP-2 gene transfer during murine fracture healing J. Bone Miner. Res. 16 2001 1837 1845
89. S. Claus, E. Aubert-Foucher, M. Demoor, B. Camuzeaux, A. Paumier, and M. Piperno et al. Chronic exposure of bone morphogenetic protein-2 favors chondrogenic expression in human articular chondrocytes amplified in monolayer cultures J. Cell. Biochem. 111 2010 1642 1651
90. A.-M. Freyria, S. Courtes, and F. Mallein-Gerin Differentiation of adult human mesenchymal stem cells: chondrogenic effect of BMP-2 Pathol. Biol. 56 2008 326 333
91. U. Valcourt, M.-C. Ronzière, P. Winkler, V. Rosen, D. Herbage, and F. Mallein-Gerin Different effects of bone morphogenetic proteins 2, 4, 12, and 13 on the expression of cartilage and bone markers in the MC615 chondrocyte cell line Exp. Cell Res. 251 1999 264 274
92. F. De Luca, K.M. Barnes, J.A. Uyeda, S. De-Levi, V. Abad, and T. Palese et al. Regulation of growth plate chondrogenesis by bone morphogenetic protein-2 Endocrinology 142 2001 430 436
93. U. Valcourt, J. Gouttenoire, A. Moustakas, D. Herbage, and F. Mallein-Gerin Functions of transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes J. Biol. Chem. 277 2002 33545 33558
94. C. Shukunami, Y. Ohta, M. Sakuda, and Y. Hiraki Sequential progression of the differentiation program by bone morphogenetic protein-2 in chondrogenic cell line ATDC5 Exp. Cell Res. 241 1998 1 11
95. P. Leboy, G. Grasso-Knight, M. D'Angelo, S.W. Volk, J.V. Lian, and H. Drissi et al. Smad-Runx interactions during chondrocyte maturation J. Bone Joint Surg. Am. 83-A Suppl. 1 2001 S15 S22
96. N. Amizuka, H. Warshawsky, J.E. Henderson, D. Goltzman, and A.C. Karaplis Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation J. Cell Biol. 126 1994 1611 1623
97. B. Lanske, and H.M. Kronenberg Parathyroid hormone-related peptide (PTHrP) and parathyroid hormone (PTH)/PTHrP receptor Crit. Rev. Eukaryot. Gene Expr. 8 1998 297 320
98. J. Weisser, S. Riemer, M. Schmidl, L.J. Suva, E. Pöschl, and R. Bräuer et al. Four distinct chondrocyte populations in the fetal bovine growth plate: highest expression levels of PTH/PTHrP receptor, Indian hedgehog, and MMP-13 in hypertrophic chondrocytes and their suppression by PTH (1-34) and PTHrP (1-40) Exp. Cell Res. 279 2002 1 13
99. H.M. Kronenberg PTHrP and skeletal development Ann. N. Y. Acad. Sci. 1068 2006 1 13
100. S. Provot, H. Kempf, L.C. Murtaugh, U.-I. Chung, D.-W. Kim, and J. Chyung et al. Nkx3.2/Bapx1 acts as a negative regulator of chondrocyte maturation Development 133 2006 651 662
101. K. Matsumoto, Y. Li, C. Jakuba, Y. Sugiyama, T. Sayo, and M. Okuno et al. Conditional inactivation of Has2 reveals a crucial role for hyaluronan in skeletal growth, patterning, chondrocyte maturation and joint formation in the developing limb Development 136 2009 2825 2835
102. M. Miura, K. Tanaka, Y. Komatsu, M. Suda, A. Yasoda, and Y. Sakuma et al. Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endochondral ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate J. Bone Miner. Res. 17 2002 443 454
103. H. Robson, T. Siebler, D.A. Stevens, S.M. Shalet, and G.R. Williams Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferation Endocrinology 141 2000 3887 3897
104. W.M. Burch, and H.E. Lebovitz Triiodothyronine stimulation of in vitro growth and maturation of embryonic chick cartilage Endocrinology 111 1982 462 468
105. C.-D. Oh, S.N. Maity, J.-F. Lu, J. Zhang, S. Liang, and F. Coustry et al. Identification of SOX9 interaction sites in the genome of chondrocytes PLoS ONE 5 2010 e10113
106. Y. Han, and V. Lefebvre L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer Mol. Cell. Biol. 28 2008 4999 5013
107. W. Huang, X. Zhou, V. Lefebvre, and B. de Crombrugghe Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer Mol. Cell. Biol. 20 2000 4149 4158
108. P. Bernard, P. Tang, S. Liu, P. Dewing, V.R. Harley, and E. Vilain Dimerization of SOX9 is required for chondrogenesis, but not for sex determination Hum. Mol. Genet. 12 2003 1755 1765
109. T. Hattori, C. Müller, S. Gebhard, E. Bauer, F. Pausch, and B. Schlund et al. SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification Development 137 2010 901 911
110. M. Kypriotou, M. Fossard-Demoor, C. Chadjichristos, C. Ghayor, B. de Crombrugghe, and J.-P. Pujol et al. SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state DNA Cell Biol. 22 2003 119 129
111. E. Duval, S. Leclercq, J.-M. Elissalde, M. Demoor, P. Galéra, and K. Boumédiene Hypoxia-inducible factor 1alpha inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1alpha-dependent redifferentiation of chondrocytes Arthritis Rheum. 60 2009 3038 3048
112. D.-W. Kim, H. Kempf, R.E. Chen, and A.B. Lassar Characterization of Nkx3.2 DNA binding specificity and its requirement for somitic chondrogenesis J. Biol. Chem. 278 2003 27532 27539
113. L. Zeng, H. Kempf, L.C. Murtaugh, M.E. Sato, and A.B. Lassar Shh establishes an Nkx3.2/Sox9 autoregulatory loop that is maintained by BMP signals to induce somitic chondrogenesis Genes Dev. 16 2002 1990 2005
114. C.J. Lengner, M.Q. Hassan, R.W. Serra, C. Lepper, A.J. van Wijnen, and J.L. Stein et al. Nkx3.2-mediated repression of Runx2 promotes chondrogenic differentiation J. Biol. Chem. 280 2005 15872 15879
115. A.-K. Wenke, S. Niebler, S. Grässel, and A.K. Bosserhoff The transcription factor AP-2ε regulates CXCL1 during cartilage development and in osteoarthritis Osteoarthr. Cartil. 19 2011 206 212
116. Z. Huang, H. Xu, and L. Sandell Negative regulation of chondrocyte differentiation by transcription factor AP-2alpha J. Bone Miner. Res. 19 2004 245 255
117. S.R. Davies, S. Sakano, Y. Zhu, and L.J. Sandell Distribution of the transcription factors Sox9, AP-2, and [delta]EF1 in adult murine articular and meniscal cartilage and growth plate J. Histochem. Cytochem. 50 2002 1059 1065
118. A.-K. Wenke, S. Grässel, M. Moser, and A.K. Bosserhoff The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes FEBS J. 276 2009 2494 2504
119. T. Sakai, A. Toyoda, K. Hashimoto, and H. Maeda Isolation and characterization of a novel zinc finger gene, ZNF219, and mapping to the human chromosome 14q11 region DNA Res. 7 2000 137 141
120. T. Sakai, K. Hino, S. Wada, and H. Maeda Identification of the DNA binding specificity of the human ZNF219 protein and its function as a transcriptional repressor DNA Res. 10 2003 155 165
121. Y. Takigawa, K. Hata, S. Muramatsu, K. Amano, K. Ono, and M. Wakabayashi et al. The transcription factor Znf219 regulates chondrocyte differentiation by assembling a transcription factory with Sox9 J. Cell Sci. 123 2010 3780 3788
122. T. Furusawa, J.-H. Lim, F. Catez, Y. Birger, S. Mackem, and M. Bustin Down-regulation of nucleosomal binding protein HMGN1 expression during embryogenesis modulates Sox9 expression in chondrocytes Mol. Cell. Biol. 26 2006 592 604
123. W.W. Curl, J. Krome, E.S. Gordon, J. Rushing, B.P. Smith, and G.G. Poehling Cartilage injuries: a review of 31,516 knee arthroscopies Arthroscopy 13 1997 456 460
124. F. Shapiro, S. Koide, and M.J. Glimcher Cell origin and differentiation in the repair of full-thickness defects of articular cartilage J. Bone Joint Surg. Am. 75 1993 532 553
125. N. Arden, and M.C. Nevitt Osteoarthritis: epidemiology Best Pract. Res. Clin. Rheumatol. 20 2006 3 25
126. M. Fransen, L. Bridgett, L. March, D. Hoy, E. Penserga, and P. Brooks The epidemiology of osteoarthritis in Asia Int. J. Rheum. Dis. 14 2011 113 121
127. P.M. van der Kraan, and W.B. van den Berg Osteoarthritis in the context of ageing and evolution. Loss of chondrocyte differentiation block during ageing Ageing Res. Rev. 7 2008 106 113
128. J.A. Gokhale, S.R. Frenkel, and P.E. Dicesare Estrogen and osteoarthritis Am. J. Orthop. 33 2004 71 80
129. J.A. Roman-Blas, S. Castañeda, R. Largo, and G. Herrero-Beaumont Osteoarthritis associated with estrogen deficiency Arthritis Res. Ther. 11 2009 241
130. M.C. Nevitt, S.R. Cummings, N.E. Lane, M.C. Hochberg, J.C. Scott, and A.R. Pressman et al. Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group Arch. Intern. Med. 156 1996 2073 2080
131. F.M. Cicuttini, and T.D. Spector Genetics of osteoarthritis Ann. Rheum. Dis. 55 1996 665 667
132. T.D. Spector, and A.J. MacGregor Risk factors for osteoarthritis: genetics Osteoarthr. Cartil. 12 Suppl. A 2004 S39 S44
133. D.T. Felson, R.C. Lawrence, P.A. Dieppe, R. Hirsch, C.G. Helmick, and J.M. Jordan et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors Ann. Intern. Med. 2000 635 646
134. R.J. Goekoop, M. Kloppenburg, H.M. Kroon, L.E.V. Dirkse, T.W.J. Huizinga, and R.G.J. Westendorp et al. Determinants of absence of osteoarthritis in old age Scand. J. Rheumatol. 40 2011 68 73
135. K. Kühn, D.D. D'Lima, S. Hashimoto, and M. Lotz Cell death in cartilage Osteoarthr. Cartil. 12 2004 1 16
136. R. Mallinger, and L. Stockinger Histochemistry of the extracellular matrix of aging hyaline cartilage Folia Histochem. Cytobiol. 25 1987 129 132
137. J.A. Martin, and J.A. Buckwalter Roles of articular cartilage aging and chondrocyte senescence in the pathogenesis of osteoarthritis Iowa Orthop. J. 21 2001 1 7
138. R.F. Loeser Aging cartilage and osteoarthritis - what's the link? Sci. Aging Knowl. Environ. 2004 2004 e31
139. A.C. Chen, M.M. Temple, D.M. Ng, N. Verzijl, J. DeGroot, and J.M. TeKoppele et al. Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage Arthritis Rheum. 46 2002 3212 3217
140. R.F. Loeser, R.R. Yammani, C.S. Carlson, H. Chen, A. Cole, and H.-J. Im et al. Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis Arthritis Rheum. 52 2005 2376 2385
141. R.R. Yammani, D. Long, and R.F. Loeser Interleukin-7 stimulates secretion of S100A4 by activating the JAK/STAT signaling pathway in human articular chondrocytes Arthritis Rheum. 60 2009 792 800
142. S.P. Grogan, and D.D. D'Lima Joint aging and chondrocyte cell death Int. J. Clin. Rheumatol. 5 2010 199 214
143. G. Martin, P. Bogdanowicz, F. Domagala, H. Ficheux, and J.-P. Pujol Articular chondrocytes cultured in hypoxia: their response to interleukin-1beta and rhein, the active metabolite of diacerhein Biorheology 41 2004 549 561
144. M.D. Carlo, and R.F. Loeser Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels Arthritis Rheum. 48 2003 3419 3430
145. B.-H. Min, H.J. Kim, H. Lim, C.S. Park, and S.R. Park Effects of ageing and arthritic disease on nitric oxide production by human articular chondrocytes Exp. Mol. Med. 33 2001 299 302
146. B. Fermor, S.E. Christensen, I. Youn, J.M. Cernanec, C.M. Davies, and J.B. Weinberg Oxygen, nitric oxide and articular cartilage Eur. Cell Mater. 13 2007 56 65 (discussion 65)
147. T. Aigner, M. Hemmel, D. Neureiter, P.M. Gebhard, G. Zeiler, and T. Kirchner et al. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritis human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage Arthritis Rheum. 44 2001 1304 1312
148. T. Aigner, and L. McKenna Molecular pathology and pathobiology of osteoarthritic cartilage Cell. Mol. Life Sci. 59 2002 5 18
149. J. Middleton, A. Manthey, and J. Tyler Insulin-like growth factor (IGF) receptor, IGF-I, interleukin-1 beta (IL-1 beta), and IL-6 mRNA expression in osteoarthritic and normal human cartilage J. Histochem. Cytochem. 44 1996 133 141
150. S. Poiraudeau Effects of growth factors on the articular cartilage Rev. Prat. 46 1996 S11 S14
151. K. Naito, M. Takahashi, K. Kushida, M. Suzuki, T. Ohishi, and M. Miura et al. Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis Rheumatology (Oxford) 38 1999 510 515
152. W.B. van den Berg Osteoarthritis year 2010 in review: pathomechanisms Osteoarthr. Cartil. 19 2011 338 341
153. A. Struglics, S. Larsson, M.A. Pratta, S. Kumar, M.W. Lark, and L.S. Lohmander Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments Osteoarthr. Cartil. 14 2006 101 113
154. F. Echtermeyer, J. Bertrand, R. Dreier, I. Meinecke, K. Neugebauer, and M. Fuerst et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis Nat. Med. 15 2009 1072 1076
155. R.F. Loeser Molecular mechanisms of cartilage destruction in osteoarthritis J. Musculoskelet. Neuronal Interact. 8 2008 303 306
156. C.S. Bonnet, and D.A. Walsh Osteoarthritis, angiogenesis and inflammation Rheumatology (Oxford) 44 2005 7 16
157. K. Hashimoto, R.O.C. Oreffo, M.B. Gibson, M.B. Goldring, and H.I. Roach DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes Arthritis Rheum. 60 2009 3303 3313
158. C. Lianxu, J. Hongti, and Y. Changlong NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes Osteoarthr. Cartil. 14 2006 367 376
159. J.A. Roman-Blas, and S.A. Jimenez NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis Osteoarthr. Cartil. 14 2006 839 848
160. J. Zumbrunn, and B. Trueb Primary structure of a putative serine protease specific for IGF-binding proteins FEBS Lett. 398 1996 187 192
161. A. De Luca, M. De Falco, A. Severino, M. Campioni, D. Santini, and F. Baldi et al. Distribution of the serine protease HtrA1 in normal human tissues J. Histochem. Cytochem. 51 2003 1279 1284
162. A. Baldi, A. De Luca, M. Morini, T. Battista, A. Felsani, and F. Baldi et al. The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells Oncogene 21 2002 6684 6688
163. V. Shridhar, A. Sen, J. Chien, J. Staub, R. Avula, and S. Kovats et al. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization Cancer Res. 62 2002 262 270
164. K.D. Hadfield, C.F. Rock, C.A. Inkson, S.L. Dallas, L. Sudre, and G.A. Wallis et al. HtrA1 inhibits mineral deposition by osteoblasts: requirement for the protease and PDZ domains J. Biol. Chem. 283 2008 5928 5938
165. A. Tsuchiya, M. Yano, J. Tocharus, H. Kojima, M. Fukumoto, and M. Kawaichi et al. Expression of mouse HtrA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis Bone 37 2005 323 336
166. S.I. Hu, M. Carozza, M. Klein, P. Nantermet, D. Luk, and R.M. Crowl Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage J. Biol. Chem. 273 1998 34406 34412
167. S. Grau, P.J. Richards, B. Kerr, C. Hughes, B. Caterson, and A.S. Williams et al. The role of human HtrA1 in arthritic disease J. Biol. Chem. 281 2006 6124 6129
168. A. Chamberland, E. Wang, A.R. Jones, L.A. Collins-Racie, E.R. LaVallie, and Y. Huang et al. Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo J. Biol. Chem. 284 2009 27352 27359
169. C. Oka, R. Tsujimoto, M. Kajikawa, K. Koshiba-Takeuchi, J. Ina, and M. Yano et al. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins Development 131 2004 1041 1053
170. T. Urano, K. Narusawa, S. Kobayashi, M. Shiraki, K. Horie-Inoue, and N. Sasaki et al. Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women J. Bone Miner. Metab. 28 2010 220 226
171. A. Dewan, M. Liu, S. Hartman, S.S.-M. Zhang, D.T.L. Liu, and C. Zhao et al. HTRA1 promoter polymorphism in wet age-related macular degeneration Science 314 2006 989 992
172. P.M. van der Kraan, E.L. Vitters, T.H. Meijers, A.R. Poole, and W.B. van den Berg Collagen type I antisense and collagen type IIA messenger RNA is expressed in adult murine articular cartilage Osteoarthr. Cartil. 6 1998 417 426
173. Y. Sasano, M. Furusawa, H. Ohtani, I. Mizoguchi, I. Takahashi, and M. Kagayama Chondrocytes synthesize type I collagen and accumulate the protein in the matrix during development of rat tibial articular cartilage Anat. Embryol. 194 1996 247 252
174. D.G. Stokes, G. Liu, R. Dharmavaram, D. Hawkins, S. Piera-Velazquez, and S.A. Jimenez Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors Biochem. J. 360 2001 461 470
175. A.N. Nur Adelina, B.S. Aminuddin, S. Munirah, K.H. Chua, N.H. Fuzina, and L. Saim et al. Phenotypic expression of collagen type II and collagen type I gene in monolayer culture of human auricular chondrocytes Med. J. Malays. 59 Suppl. B 2004 188 189
176. M. Schnabel, S. Marlovits, G. Eckhoff, I. Fichtel, L. Gotzen, and V. Vécsei et al. Dedifferentiation-associated changes in morphology and gene expression in primary human articular chondrocytes in cell culture Osteoarthr. Cartil. 10 2002 62 70
177. M. Kypriotou, G. Beauchef, C. Chadjichristos, R. Widom, E. Renard, and S.A. Jimenez et al. Human collagen Krox up-regulates type I collagen expression in normal and scleroderma fibroblasts through interaction with Sp1 and Sp3 transcription factors J. Biol. Chem. 282 2007 32000 32014
178. S.J. Chen, C.M. Artlett, S.A. Jimenez, and J. Varga Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro Gene 215 1998 101 110
179. G. Beauchef, N. Bigot, M. Kypriotou, E. Renard, B. Porée, and R. Widom et al. The p65 subunit of NF-κb inhibits col1a1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on the promoter by protein interaction with transcriptional activators (c-Krox, Sp1 and Sp3) J. Biol. Chem. 287 2012 3462 3478
180. C. Ghayor, C. Chadjichristos, J.F. Herrouin, L. Ala-Kokko, G. Suske, and J.-P. Pujol et al. Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes J. Biol. Chem. 276 2001 36881 36895
181. A.K. Ghosh Factors involved in the regulation of type I collagen gene expression: implication in fibrosis Exp. Biol. Med. (Maywood) 227 2002 301 314
182. L. Peterson, T. Minas, M. Brittberg, A. Nilsson, E. Sjögren-Jansson, and A. Lindahl Two- to 9-year outcome after autologous chondrocyte transplantation of the knee Clin. Orthop. Relat. Res. 2000 212 234
183. L. Peterson, H.S. Vasiliadis, M. Brittberg, and A. Lindahl Autologous chondrocyte implantation: a long-term follow-up Am. J. Sports Med. 38 2010 1117 1124
184. L. Peterson, M. Brittberg, I. Kiviranta, E.L. Akerlund, and A. Lindahl Autologous chondrocyte transplantation. Biomechanics and long-term durability Am. J. Sports Med. 30 2002 2 12
185. S. Marlovits, P. Zeller, P. Singer, C. Resinger, and V. Vécsei Cartilage repair: generations of autologous chondrocyte transplantation Eur. J. Radiol. 57 2006 24 31
186. M.W. Kessler, G. Ackerman, J.S. Dines, and D. Grande Emerging technologies and fourth generation issues in cartilage repair Sports Med. Arthrosc. 16 2008 246 254
187. M. Demoor, L. Maneix, D. Ollitrault, F. Legendre, E. Duval, and S. Claus et al. Deciphering chondrocyte behaviour in matrix-induced autologous chondrocyte implantation to undergo accurate cartilage repair with hyaline matrix Pathol. Biol. 60 2012 199 207
188. C. Vinatier, D. Mrugala, C. Jorgensen, J. Guicheux, and D. Noel Cartilage engineering: a crucial combination of cells, biomaterials and biofactors Trends Biotechnol. 27 2009 307 314
189. L. da Silva Meirelles, P.C. Chagastelles, and N.B. Nardi Mesenchymal stem cells reside in virtually all post-natal organs and tissues J. Cell Sci. 119 2006 2204 2213
190. P. Pastides, M. Chimutengwende-Gordon, N. Maffulli, and W. Khan Stem cell therapy for human cartilage defects: a systematic review Osteoarthr. Cartil. 21 2013 646 654
191. H. Wegmeyer, A.-M. Bröske, M. Leddin, K. Kuentzer, A.K. Nisslbeck, and J. Hupfeld et al. Mesenchymal stromal cell characteristics vary depending on their origin Stem Cells Dev. 22 2013 2606 2618
192. P.S. in 't Anker, W.A. Noort, S.A. Scherjon, C. Kleijburg-van der Keur, A.B. Kruisselbrink, and R.L. van Bezooijen et al. Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential Haematologica 88 2003 845 852
193. M.W. Lee, D.S. Kim, K.H. Yoo, H.R. Kim, I.K. Jang, and J.H. Lee et al. Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions Blood Res. 48 2013 107 114
194. W. Wagner, R.E. Feldmann, A. Seckinger, M.H. Maurer, F. Wein, and J. Blake et al. The heterogeneity of human mesenchymal stem cell preparations - evidence from simultaneous analysis of proteomes and transcriptomes Exp. Hematol. 34 2006 536 548
195. T. Aoi, K. Yae, M. Nakagawa, T. Ichisaka, K. Okita, and K. Takahashi et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells Science 321 2008 699 702
196. K. Hiramatsu, S. Sasagawa, H. Outani, K. Nakagawa, H. Yoshikawa, and N. Tsumaki Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors J. Clin. Invest. 121 2011 640 657
197. K. Le Blanc, L. Tammik, B. Sundberg, S.E. Haynesworth, and O. Ringdén Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex Scand. J. Immunol. 57 2003 11 20
198. I. Rasmusson Immune modulation by mesenchymal stem cells Exp. Cell Res. 312 2006 2169 2179
199. R.H. Lee, B. Kim, I. Choi, H. Kim, H.S. Choi, and K. Suh et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue Cell. Physiol. Biochem. 14 2004 311 324
200. R. McBeath, D.M. Pirone, C.M. Nelson, K. Bhadriraju, and C.S. Chen Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment Dev. Cell 6 2004 483 495
201. C. Jorgensen Mesenchymal stem cells in arthritis: role of bone marrow microenvironment Arthritis Res. Ther. 12 2010 135
202. C.K. Kuo, and R.S. Tuan Tissue engineering with mesenchymal stem cells IEEE Eng. Med. Biol. Mag. 22 2003 51 56
203. H. Koga, T. Muneta, T. Nagase, A. Nimura, Y.-J. Ju, and T. Mochizuki et al. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit Cell Tissue Res. 333 2008 207 215
204. K. Bieback, S. Kern, H. Klüter, and H. Eichler Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood Stem Cells 22 2004 625 634
205. M. Wang, Y. Yang, D. Yang, F. Luo, W. Liang, and S. Guo et al. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro Immunology 126 2009 220 232
206. F. Granero-Moltó, J.A. Weis, L. Longobardi, and A. Spagnoli Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair Expert. Opin. Biol. Ther. 8 2008 255 268
207. G.M. van Buul, E. Villafuertes, P.K. Bos, J.H. Waarsing, N. Kops, and R. Narcisi et al. Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture Osteoarthr. Cartil. 20 2012 1186 1196
208. L. Wu, H.-J. Prins, M.N. Helder, C.A. van Blitterswijk, and M. Karperien Trophic effects of mesenchymal stem cells in chondrocyte co-cultures are independent of culture conditions and cell sources Tissue Eng. A 18 2012 1542 1551
209. S.Y. Jeong, D.H. Kim, J. Ha, H.J. Jin, S.-J. Kwon, and J.W. Chang et al. Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation Stem Cells 31 2013 2136 2148
210. C.S. de Mara, A.S.S. Duarte, A.R. Sartori-Cintra, A.C.M. Luzo, S.T.O. Saad, and I.B. Coimbra Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6 Rheumatol. Int. 33 2013 121 128
211. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, and J.D. Mosca et al. Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
212. P.A. Conget, and J.J. Minguell Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells J. Cell. Physiol. 181 1999 67 73
213. V. Sordi, M.L. Malosio, F. Marchesi, A. Mercalli, R. Melzi, and T. Giordano et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets Blood 106 2005 419 427
214. S.E. Haynesworth, M.A. Baber, and A.I. Caplan Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies Bone 13 1992 69 80
215. M.C. Galmiche, V.E. Koteliansky, J. Brière, P. Hervé, and P. Charbord Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway Blood 82 1993 66 76
216. K. Le Blanc, C. Tammik, K. Rosendahl, E. Zetterberg, and O. Ringdén HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells Exp. Hematol. 31 2003 890 896
217. D. Baksh, R. Yao, and R.S. Tuan Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow Stem Cells 25 2007 1384 1392
218. E. Flores-Torales, A. Orozco-Barocio, O.R. Gonzalez-Ramella, A. Carrasco-Yalan, K. Gazarian, and S. Cuneo-Pareto The CD271 expression could be alone for establisher phenotypic marker in bone marrow derived mesenchymal stem cells Folia Histochem. Cytobiol. 48 2010 682 686
219. S. Kuçi, Z. Kuçi, H. Kreyenberg, E. Deak, K. Pütsch, and S. Huenecke et al. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties Haematologica 95 2010 651 659
220. P.A. Zuk, M. Zhu, P. Ashjian, D.A. De Ugarte, J.I. Huang, and H. Mizuno et al. Human adipose tissue is a source of multipotent stem cells Mol. Biol. Cell 13 2002 4279 4295
221. P. Mafi, S. Hindocha, R. Mafi, M. Griffin, and W.S. Khan Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature Open Orthop. J. 5 2011 253 260
222. A. Tárnok, H. Ulrich, and J. Bocsi Phenotypes of stem cells from diverse origin Cytometry A 77 2010 6 10
223. E.H. Javazon, K.J. Beggs, and A.W. Flake Mesenchymal stem cells: paradoxes of passaging Exp. Hematol. 32 2004 414 425
224. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, and D. Krause et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
225. P. Bianco, X. Cao, P.S. Frenette, J.J. Mao, P.G. Robey, and P.J. Simmons et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine Nat. Med. 19 2013 35 42
226. F. Sabatini, L. Petecchia, M. Tavian, V. Jodon de Villeroché, G.A. Rossi, and D. Brouty-Boyé Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities Lab. Invest. 85 2005 962 971
227. H.-J. Bühring, V.L. Battula, S. Treml, B. Schewe, L. Kanz, and W. Vogel Novel markers for the prospective isolation of human MSC Ann. N. Y. Acad. Sci. 1106 2007 262 271
228. V.L. Battula, S. Treml, P.M. Bareiss, F. Gieseke, H. Roelofs, and P. de Zwart et al. Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1 Haematologica 94 2009 173 184
229. Y. Mabuchi, S. Morikawa, S. Harada, K. Niibe, S. Suzuki, and F. Renault-Mihara et al. LNGFR(+)THY-1(+)VCAM-1(hi +) cells reveal functionally distinct subpopulations in mesenchymal stem cells Stem Cell Rep. 1 2013 152 165
230. A. Bakopoulou, G. Leyhausen, J. Volk, P. Koidis, and W. Geurtsen Comparative characterization of STRO-1(neg)/CD146(pos) and STRO-1(pos)/ CD146(pos) apical papilla stem cells enriched with flow cytometry Arch. Oral Biol. 58 2013 1556 1568
231. S. Gronthos, S.E. Graves, S. Ohta, and P.J. Simmons The STRO-1 + fraction of adult human bone marrow contains the osteogenic precursors Blood 84 1994 4164 4173
232. J.E. Dennis, J.-P. Carbillet, A.I. Caplan, and P. Charbord The STRO-1 + marrow cell population is multipotential Cells Tissues Organs 170 2002 73 82
233. L. Gan, and R.A. Kandel In vitro cartilage tissue formation by co-culture of primary and passaged chondrocytes Tissue Eng. 13 2007 831 842
234. A.R. Tan, E.Y. Dong, J.P. Andry, J.C. Bulinski, G.A. Ateshian, and C.T. Hung Coculture of engineered cartilage with primary chondrocytes induces expedited growth Clin. Orthop. Relat. Res. 469 2011 2735 2743
235. J. Jiang, S.B. Nicoll, and H.H. Lu Co-culture of osteoblasts and chondrocytes modulates cellular differentiation in vitro Biochem. Biophys. Res. Commun. 338 2005 762 770
236. R. Nakaoka, S.X. Hsiong, and D.J. Mooney Regulation of chondrocyte differentiation level via co-culture with osteoblasts Tissue Eng. 12 2006 2425 2433
237. N. Bigdeli, C. Karlsson, R. Strehl, S. Concaro, J. Hyllner, and A. Lindahl Coculture of human embryonic stem cells and human articular chondrocytes results in significantly altered phenotype and improved chondrogenic differentiation Stem Cells 27 2009 1812 1821
238. G.M. Hoben, V.P. Willard, and K.A. Athanasiou Fibrochondrogenesis of hESCs: growth factor combinations and cocultures Stem Cells Dev. 18 2009 283 292
239. K. Tsuchiya, G. Chen, T. Ushida, T. Matsuno, and T. Tateishi The effect of coculture of chondrocytes with mesenchymal stem cells on their cartilaginous phenotype in vitro Mater. Sci. Eng. C 24 2004 391 396
240. S. Giovannini, J. Diaz-Romero, T. Aigner, P. Heini, P. Mainil-Varlet, and D. Nesic Micromass co-culture of human articular chondrocytes and human bone marrow mesenchymal stem cells to investigate stable neocartilage tissue formation in vitro Eur. Cell Mater. 20 2010 245 259
241. E.J. Levorson, P.M. Mountziaris, O. Hu, F.K. Kasper, and A.G. Mikos Cell derived polymer/extracellular matrix composite scaffolds for cartilage regeneration, part 1: investigation of co-cultures and seeding densities for improved extracellular matrix deposition Tissue Eng. C Methods 2013 (in press)
242. Y. Wei, W. Zeng, R. Wan, J. Wang, Q. Zhou, and S. Qiu et al. Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix Eur. Cell Mater. 23 2012 1 12
243. D.A. Grande, C. Halberstadt, G. Naughton, R. Schwartz, and R. Manji Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts J. Biomed. Mater. Res. 34 1997 211 220
244. H.A. Awad, M.Q. Wickham, H.A. Leddy, J.M. Gimble, and F. Guilak Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds Biomaterials 25 2004 3211 3222
245. L.H. Nguyen, A.K. Kudva, N.L. Guckert, K.D. Linse, and K. Roy Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage Biomaterials 32 2011 1327 1338
246. D. Puppi, F. Chiellini, A.M. Piras, and E. Chiellini Polymeric materials for bone and cartilage repair Prog. Polym. Sci. 35 2010 403 440
247. J. Raghunath, J. Rollo, K.M. Sales, P.E. Butler, and A.M. Seifalian Biomaterials and scaffold design: key to tissue-engineering cartilage Biotechnol. Appl. Biochem. 46 2007 73 84
248. A.M. Haleem, and C.R. Chu Advances in tissue engineering techniques for articular cartilage repair Oper. Tech. Orthop. 20 2010 76 89
249. A. Matsiko, T. Levingstone, and F. O'Brien Advanced strategies for articular cartilage defect repair Materials 6 2013 637 668
250. A. Gigante, C. Bevilacqua, A. Ricevuto, M. Mattioli-Belmonte, and F. Greco Membrane-seeded autologous chondrocytes: cell viability and characterization at surgery Knee Surg. Sports Traumatol. Arthrosc. 15 2007 88 92
251. A.-M. Freyria, M.-C. Ronzière, D. Cortial, L. Galois, D. Hartmann, and D. Herbage et al. Comparative phenotypic analysis of articular chondrocytes cultured within type I or type II collagen scaffolds Tissue Eng. A 15 2009 1233 1245
252. T. Mukaida, K. Urabe, K. Naruse, J. Aikawa, M. Katano, and S.-H. Hyon et al. Influence of three-dimensional culture in a type II collagen sponge on primary cultured and dedifferentiated chondrocytes J. Orthop. Sci. 10 2005 521 528
253. B. Rahfoth, J. Weisser, F. Sternkopf, T. Aigner, K. von der Mark, and R. Bräuer Transplantation of allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits Osteoarthr. Cartil. 6 1998 50 65
254. C. Domm, M. Schünke, K. Christesen, and B. Kurz Redifferentiation of dedifferentiated bovine articular chondrocytes in alginate culture under low oxygen tension Osteoarthr. Cartil. 10 2002 13 22
255. Y.A. Lee, S.-S. Kang, S.-H. Baek, J.-C. Jung, E.-J. Jin, and E.N. Tak et al. Redifferentiation of dedifferentiated chondrocytes on chitosan membranes and involvement of PKCalpha and P38 MAP kinase Mol. Cells 24 2007 9 15
256. H. Tan, Y. Gong, L. Lao, Z. Mao, and C. Gao Gelatin/chitosan/hyaluronan ternary complex scaffold containing basic fibroblast growth factor for cartilage tissue engineering J. Mater. Sci. Mater. Med. 18 2007 1961 1968
257. B. Shen, A. Wei, H. Tao, A.D. Diwan, and D.D.F. Ma BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture Tissue Eng. A 15 2009 1311 1320
258. B. Grigolo, G. Lisignoli, A. Piacentini, M. Fiorini, P. Gobbi, and G. Mazzotti et al. Evidence for redifferentiation of human chondrocytes grown on a hyaluronan-based biomaterial (HYAff 11): molecular, immunohistochemical and ultrastructural analysis Biomaterials 23 2002 1187 1195
259. Y. Dausse, L. Grossin, G. Miralles, S. Pelletier, D. Mainard, and P. Hubert et al. Cartilage repair using new polysaccharidic biomaterials: macroscopic, histological and biochemical approaches in a rat model of cartilage defect Osteoarthr. Cartil. 11 2003 16 28
260. C.R. Correia, L.S. Moreira-Teixeira, L. Moroni, R.L. Reis, C.A. van Blitterswijk, and M. Karperien et al. Chitosan scaffolds containing hyaluronic acid for cartilage tissue engineering Tissue Eng. C Methods 17 2011 717 730
261. N. Bhardwaj, Q.T. Nguyen, A.C. Chen, D.L. Kaplan, R.L. Sah, and S.C. Kundu Potential of 3-D tissue constructs engineered from bovine chondrocytes/silk fibroin-chitosan for in vitro cartilage tissue engineering Biomaterials 32 2011 5773 5781
262. P.C. Kreuz, S. Müller, U. Freymann, C. Erggelet, P. Niemeyer, and C. Kaps et al. Repair of focal cartilage defects with scaffold-assisted autologous chondrocyte grafts: clinical and biomechanical results 48 months after transplantation Am. J. Sports Med. 39 2011 1697 1705
263. M.S. Rahman, and T. Tsuchiya Enhancement of chondrogenic differentiation of human articular chondrocytes by biodegradable polymers Tissue Eng. 7 2001 781 790
264. G.D. Nicodemus, I. Villanueva, and S.J. Bryant Mechanical stimulation of TMJ condylar chondrocytes encapsulated in PEG hydrogels J. Biomed. Mater. Res. A 83 2007 323 331
265. C. Matsuda, M. Takagi, T. Hattori, S. Wakitani, and T. Yoshida Differentiation of human bone marrow mesenchymal stem cells to chondrocytes for construction of three-dimensional cartilage tissue Cytotechnology 47 2005 11 17
266. D. Hannouche, H. Terai, J.R. Fuchs, S. Terada, S. Zand, and B.A. Nasseri et al. Engineering of implantable cartilaginous structures from bone marrow-derived mesenchymal stem cells Tissue Eng. 13 2007 87 99
267. Y. Tanaka, H. Yamaoka, S. Nishizawa, S. Nagata, T. Ogasawara, and Y. Asawa et al. The optimization of porous polymeric scaffolds for chondrocyte/atelocollagen based tissue-engineered cartilage Biomaterials 31 2010 4506 4516
268. W. Dai, N. Kawazoe, X. Lin, J. Dong, and G. Chen The influence of structural design of PLGA/collagen hybrid scaffolds in cartilage tissue engineering Biomaterials 31 2010 2141 2152
269. M. You, G. Peng, J. Li, P. Ma, Z. Wang, and W. Shu et al. Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide Biomaterials 32 2011 2305 2313
270. E.J. Lee, F.K. Kasper, and A.G. Mikos Biomaterials for tissue engineering Ann. Biomed. Eng. 42 2013 323 337
271. L.H. Nguyen, A.K. Kudva, N.S. Saxena, and K. Roy Engineering articular cartilage with spatially-varying matrix composition and mechanical properties from a single stem cell population using a multi-layered hydrogel Biomaterials 32 2011 6946 6952
272. Z. Ge, C. Li, B.C. Heng, G. Cao, and Z. Yang Functional biomaterials for cartilage regeneration J. Biomed. Mater. Res. A 100 2012 2526 2536
273. R.M. Schulz, and A. Bader Cartilage tissue engineering and bioreactor systems for the cultivation and stimulation of chondrocytes Eur. Biophys. J. 36 2007 539 568
274. N. Mabvuure, S. Hindocha, and W.S. Khan The role of bioreactors in cartilage tissue engineering Curr. Stem Cell Res. Ther. 7 2012 287 292
275. Z. Ivanovic Hypoxia or in situ normoxia: the stem cell paradigm J. Cell. Physiol. 219 2009 271 275
276. W.G. Kaelin, and P.J. Ratcliffe Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway Mol. Cell 30 2008 393 402
277. G.L. Semenza HIF-1 and mechanisms of hypoxia sensing Curr. Opin. Cell Biol. 13 2001 167 171
278. G.L. Semenza Hypoxia-inducible factor 1 (HIF-1) pathway Sci. STKE 2007 cm8
279. S. Provot, D. Zinyk, Y. Gunes, R. Kathri, Q. Le, and H.M. Kronenberg et al. Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development J. Cell Biol. 177 2007 451 464
280. E. Schipani, H.E. Ryan, S. Didrickson, T. Kobayashi, M. Knight, and R.S. Johnson Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival Genes Dev. 15 2001 2865 2876
281. E. Zelzer, R. Mamluk, N. Ferrara, R.S. Johnson, E. Schipani, and B.R. Olsen VEGFA is necessary for chondrocyte survival during bone development Development 131 2004 2161 2171
282. D. Pfander, T. Cramer, E. Schipani, and R.S. Johnson HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes J. Cell Sci. 116 2003 1819 1826
283. E. Aro, R. Khatri, R. Gerard-O'Riley, L. Mangiavini, J. Myllyharju, and E. Schipani Hypoxia-inducible factor-1 (HIF-1) but not HIF-2 is essential for hypoxic induction of collagen prolyl 4-hydroxylases in primary newborn mouse epiphyseal growth plate chondrocytes J. Biol. Chem. 287 2012 37134 37144
284. L. Bentovim, R. Amarilio, and E. Zelzer HIF1α is a central regulator of collagen hydroxylation and secretion under hypoxia during bone development Development 139 2012 4473 4483
285. M. Ema, S. Taya, N. Yokotani, K. Sogawa, Y. Matsuda, and Y. Fujii-Kuriyama A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development Proc. Natl. Acad. Sci. U. S. A. 94 1997 4273 4278
286. H.M. Sowter, R.R. Raval, J.W. Moore, P.J. Ratcliffe, and A.L. Harris Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia Cancer Res. 63 2003 6130 6134
287. T. Saito, A. Fukai, A. Mabuchi, T. Ikeda, F. Yano, and S. Ohba et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development Nat. Med. 16 2010 678 686
288. S. Yang, J. Kim, J.-H. Ryu, H. Oh, C.-H. Chun, and B.J. Kim et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction Nat. Med. 16 2010 687 693
289. B.L. Thoms, K.A. Dudek, J.E. Lafont, and C.L. Murphy Hypoxia promotes the production and inhibits the destruction of human articular cartilage Arthritis Rheum. 65 2013 1302 1312
290. J.E. Lafont, S. Talma, C. Hopfgarten, and C.L. Murphy Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways J. Biol. Chem. 283 2008 4778 4786
291. J.E. Lafont, S. Talma, and C.L. Murphy Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype Arthritis Rheum. 56 2007 3297 3306
292. C.B. Foldager, A.B. Nielsen, S. Munir, M. Ulrich-Vinther, K. Søballe, and C. Bünger et al. Combined 3D and hypoxic culture improves cartilage-specific gene expression in human chondrocytes Acta Orthop. 82 2011 234 240
293. P. Malladi, Y. Xu, M. Chiou, A.J. Giaccia, and M.T. Longaker Effect of reduced oxygen tension on chondrogenesis and osteogenesis in adipose-derived mesenchymal cells Am. J. Physiol. Cell Physiol. 290 2006 C1139 C1146
294. B.D. Markway, G.-K. Tan, G. Brooke, J.E. Hudson, J.J. Cooper-White, and M.R. Doran Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures Cell Transplant. 19 2010 29 42
295. L.F. Raheja, D.C. Genetos, A. Wong, and C.E. Yellowley Hypoxic regulation of mesenchymal stem cell migration: the role of RhoA and HIF-1α Cell Biol. Int. 35 2011 981 989
296. J.H. Kim, S.-H. Park, S.G. Park, J.-S. Choi, Y. Xia, and J.-H. Sung The pivotal role of reactive oxygen species generation in the hypoxia-induced stimulation of adipose-derived stem cells Stem Cells Dev. 20 2011 1753 1761
297. K. Pelttari, E. Steck, and W. Richter The use of mesenchymal stem cells for chondrogenesis Injury 39 Suppl. 1 2008 S58 S65
298. O.F.W. Gardner, C.W. Archer, M. Alini, and M.J. Stoddart Chondrogenesis of mesenchymal stem cells for cartilage tissue engineering Histol. Histopathol. 28 2013 23 42
299. Ronzière M.-C., E. Perrier, F. Mallein-Gerin, and A.-M. Freyria Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells Biomed. Mater. Eng. 20 2010 145 158
300. E.M. Darling, and K.A. Athanasiou Articular cartilage bioreactors and bioprocesses Tissue Eng. 9 2003 9 26
301. C.V. Gemmiti, and R.E. Guldberg Fluid flow increases type II collagen deposition and tensile mechanical properties in bioreactor-grown tissue-engineered cartilage Tissue Eng. 12 2006 469 479
302. S.C. Tran, A.J. Cooley, and S.H. Elder Effect of a mechanical stimulation bioreactor on tissue engineered, scaffold-free cartilage Biotechnol. Bioeng. 108 2011 1421 1429
303. B.D. Elder, and K.A. Athanasiou Hydrostatic pressure in articular cartilage tissue engineering: from chondrocytes to tissue regeneration Tissue Eng. B Rev. 15 2009 43 53
304. A. Barlic, M. Drobnic, E. Malicev, and N. Kregar-Velikonja Quantitative analysis of gene expression in human articular chondrocytes assigned for autologous implantation J. Orthop. Res. 26 2008 847 853
305. C. Bougault, A. Paumier, E. Aubert-Foucher, and F. Mallein-Gerin Molecular analysis of chondrocytes cultured in agarose in response to dynamic compression BMC Biotechnol. 8 2008 71
306. C. Bougault, A. Paumier, E. Aubert-Foucher, and F. Mallein-Gerin Investigating conversion of mechanical force into biochemical signaling in three-dimensional chondrocyte cultures Nat. Protoc. 4 2009 928 938
307. C. Bougault, E. Aubert-Foucher, A. Paumier, E. Perrier-Groult, L. Huot, and D. Hot et al. Dynamic compression of chondrocyte-agarose constructs reveals new candidate mechanosensitive genes PLoS ONE 7 2012 e36964
308. K. Lee, E.A. Silva, and D.J. Mooney Growth factor delivery-based tissue engineering: general approaches and a review of recent developments J. R. Soc. Interface 8 2011 153 170
309. F. Rédini, M. Daireaux, A. Mauviel, P. Galéra, G. Loyau, and J.-P. Pujol Characterization of proteoglycans synthesized by rabbit articular chondrocytes in response to transforming growth factor-beta (TGF-beta) Biochim. Biophys. Acta 1093 1991 196 206
310. P. Galéra, D. Vivien, S. Pronost, J. Bonaventure, F. Rédini, and G. Loyau et al. Transforming growth factor-beta 1 (TGF-beta 1) up-regulation of collagen type II in primary cultures of rabbit articular chondrocytes (RAC) involves increased mRNA levels without affecting mRNA stability and procollagen processing J. Cell. Physiol. 153 1992 596 606
311. P. Galéra, F. Rédini, D. Vivien, J. Bonaventure, H. Penfornis, and G. Loyau et al. Effect of transforming growth factor-beta 1 (TGF-beta 1) on matrix synthesis by monolayer cultures of rabbit articular chondrocytes during the dedifferentiation process Exp. Cell Res. 200 1992 379 392
312. P.C. Yaeger, T.L. Masi, J.L. de Ortiz, F. Binette, R. Tubo, and J.M. McPherson Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes Exp. Cell Res. 237 1997 318 325
313. H. Park, J.S. Temenoff, T.A. Holland, Y. Tabata, and A.G. Mikos Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications Biomaterials 26 2005 7095 7103
314. J.S. Park, D.G. Woo, H.N. Yang, K. Na, and K.-H. Park Transforming growth factor beta-3 bound with sulfate polysaccharide in synthetic extracellular matrix enhanced the biological activities for neocartilage formation in vivo J Biomed. Mater. Res. A 91 2009 408 415
315. M. Pecina, M. Jelic, S. Martinovic, M. Haspl, and S. Vukicevic Articular cartilage repair: the role of bone morphogenetic proteins Int. Orthop. 26 2002 131 136
316. L.Z. Sailor, R.M. Hewick, and E.A. Morris Recombinant human bone morphogenetic protein-2 maintains the articular chondrocyte phenotype in long-term culture J. Orthop. Res. 14 1996 937 945
317. A. Hautier, V. Salentey, E. Aubert-Foucher, C. Bougault, G. Beauchef, and M.-C. Ronzière et al. Bone morphogenetic protein-2 stimulates chondrogenic expression in human nasal chondrocytes expanded in vitro Growth Factors 26 2008 201 211
318. D.A. Krawczak, J.J. Westendorf, C.S. Carlson, and J.L. Lewis Influence of bone morphogenetic protein-2 on the extracellular matrix, material properties, and gene expression of long-term articular chondrocyte cultures: loss of chondrocyte stability Tissue Eng. A. 15 2009 1247 1255
319. H. Yamaoka, H. Asato, T. Ogasawara, S. Nishizawa, T. Takahashi, and T. Nakatsuka et al. Cartilage tissue engineering using human auricular chondrocytes embedded in different hydrogel materials J. Biomed. Mater. Res. A 78 2006 1 11
320. E. Perrier-Groult, M. Pasdeloup, M. Malbouyres, P. Galéra, and F. Mallein-Gerin Control of collagen production in mouse chondrocytes by using a combination of bone morphogenetic protein-2 and small interfering RNA targeting Col1a1 for hydrogel-based tissue-engineered cartilage Tissue Eng. C Methods 19 2013 652 664
321. D.L. Hicks, A.B. Sage, E. Shelton, B.L. Schumacher, R.L. Sah, and D. Watson Effect of bone morphogenetic proteins 2 and 7 on septal chondrocytes in alginate Otolaryngol. Head Neck Surg. 136 2007 373 379
322. T. Gründer, C. Gaissmaier, J. Fritz, R. Stoop, P. Hortschansky, and J. Mollenhauer et al. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads Osteoarthr. Cartil. 12 2004 559 567
323. G. Liu, H. Kawaguchi, T. Ogasawara, Y. Asawa, J. Kishimoto, and T. Takahashi et al. Optimal combination of soluble factors for tissue engineering of permanent cartilage from cultured human chondrocytes J. Biol. Chem. 282 2007 20407 20415
324. A. Jonitz, K. Lochner, T. Tischer, D. Hansmann, and R. Bader TGF-β1 and IGF-1 influence the re-differentiation capacity of human chondrocytes in 3D pellet cultures in relation to different oxygen concentrations Int. J. Mol. Med. 30 2012 666 672
325. I. Martin, R. Suetterlin, W. Baschong, M. Heberer, G. Vunjak-Novakovic, and L.E. Freed Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF-2 during 2D expansion and BMP-2 during 3D cultivation J. Cell. Biochem. 83 2001 121 128
326. E.W. Mandl, H. Jahr, J.L.M. Koevoet, J.P.T.M. van Leeuwen, H. Weinans, and J.A.N. Verhaar et al. Fibroblast growth factor-2 in serum-free medium is a potent mitogen and reduces dedifferentiation of human ear chondrocytes in monolayer culture Matrix Biol. 23 2004 231 241
327. S. Claus, N. Mayer, E. Aubert-Foucher, H. Chajra, E. Perrier-Groult, and J. Lafont et al. Cartilage-characteristic matrix reconstruction by sequential addition of soluble factors during expansion of human articular chondrocytes and their cultivation in collagen sponges Tissue Eng. C Methods 18 2012 104 112
328. E.C. Ko, Y. Fujihara, T. Ogasawara, Y. Asawa, S. Nishizawa, and S. Nagata et al. BMP-2 embedded atelocollagen scaffold for tissue-engineered cartilage cultured in the medium containing insulin and triiodothyronine - a new protocol for three-dimensional in vitro culture of human chondrocytes Tissue Eng. C Methods 18 2012 374 386
329. N. Veilleux, and M. Spector Effects of FGF-2 and IGF-1 on adult canine articular chondrocytes in type II collagen-glycosaminoglycan scaffolds in vitro Osteoarthr. Cartil. 13 2005 278 286
330. M. Pei, J. Seidel, G. Vunjak-Novakovic, and L.E. Freed Growth factors for sequential cellular de- and re-differentiation in tissue engineering Biochem. Biophys. Res. Commun. 294 2002 149 154
331. K.W. Ng, C.J. O'Conor, L.E. Kugler, J.L. Cook, G.A. Ateshian, and C.T. Hung Transient supplementation of anabolic growth factors rapidly stimulates matrix synthesis in engineered cartilage Ann. Biomed. Eng. 39 2011 2491 2500
332. J.L. Puetzer, J.N. Petitte, and E.G. Loboa Comparative review of growth factors for induction of three-dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue Tissue Eng. B Rev. 16 2010 435 444
333. A.-M. Freyria, and F. Mallein-Gerin Chondrocytes or adult stem cells for cartilage repair: the indisputable role of growth factors Injury 43 2012 259 265
334. K.W. Kavalkovich, R.E. Boynton, J.M. Murphy, and F. Barry Chondrogenic differentiation of human mesenchymal stem cells within an alginate layer culture system In Vitro Cell. Dev. Biol. Anim. 38 2002 457 466
335. H. Fan, H. Tao, Y. Wu, Y. Hu, Y. Yan, and Z. Luo TGF-β3 immobilized PLGA-gelatin/chondroitin sulfate/hyaluronic acid hybrid scaffold for cartilage regeneration J. Biomed. Mater. Res. A 95 2010 982 992
336. I. Sekiya, B.L. Larson, J.T. Vuoristo, R.L. Reger, and D.J. Prockop Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma Cell Tissue Res. 320 2005 269 276
337. Y. Park, M. Sugimoto, A. Watrin, M. Chiquet, and E.B. Hunziker BMP-2 induces the expression of chondrocyte-specific genes in bovine synovium-derived progenitor cells cultured in three-dimensional alginate hydrogel Osteoarthr. Cartil. 13 2005 527 536
338. T. Kurth, E. Hedbom, N. Shintani, M. Sugimoto, F.H. Chen, and M. Haspl et al. Chondrogenic potential of human synovial mesenchymal stem cells in alginate Osteoarthr. Cartil. 15 2007 1178 1189
339. U. Nöth, L. Rackwitz, A. Heymer, M. Weber, B. Baumann, and A. Steinert et al. Chondrogenic differentiation of human mesenchymal stem cells in collagen type I hydrogels J. Biomed. Mater. Res. A 83 2007 626 635
340. S. Weiss, T. Hennig, R. Bock, E. Steck, and W. Richter Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells J. Cell. Physiol. 223 2010 84 93
341. K. Kieswetter, Z. Schwartz, M. Alderete, D.D. Dean, and B.D. Boyan Platelet derived growth factor stimulates chondrocyte proliferation but prevents endochondral maturation Endocrine 6 1997 257 264
342. F.-M. Chen, L.-A. Wu, M. Zhang, R. Zhang, and H.-H. Sun Homing of endogenous stem/progenitor cells for in situ tissue regeneration: promises, strategies, and translational perspectives Biomaterials 32 2011 3189 3209
343. R.S. Sellers, R. Zhang, S.S. Glasson, H.D. Kim, D. Peluso, and D.A. D'Augusta et al. Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (rhBMP-2) J. Bone Joint Surg. Am. 82 2000 151 160
344. N. Tamai, A. Myoui, M. Hirao, T. Kaito, T. Ochi, and J. Tanaka et al. A new biotechnology for articular cartilage repair: subchondral implantation of a composite of interconnected porous hydroxyapatite, synthetic polymer (PLA-PEG), and bone morphogenetic protein-2 (rhBMP-2) Osteoarthr. Cartil. 13 2005 405 417
345. C.H. Lee, J.L. Cook, A. Mendelson, E.K. Moioli, H. Yao, and J.J. Mao Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study Lancet 376 2010 440 448
346. L.A. Fortier, J.U. Barker, E.J. Strauss, T.M. McCarrel, and B.J. Cole The role of growth factors in cartilage repair Clin. Orthop. Relat. Res. 469 2011 2706 2715
347. M.B. Schmidt, E.H. Chen, and S.E. Lynch A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair Osteoarthr. Cartil. 14 2006 403 412
348. C.H. Evans, P.D. Robbins, S.C. Ghivizzani, J.H. Herndon, R. Kang, and A.B. Bahnson et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis Hum. Gene Ther. 7 1996 1261 1280
349. A.F. Steinert, U. Nöth, and R.S. Tuan Concepts in gene therapy for cartilage repair Injury 39 Suppl. 1 2008 S97 S113
350. F.D. Shuler, H.I. Georgescu, C. Niyibizi, R.K. Studer, Z. Mi, and B. Johnstone et al. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes J. Orthop. Res. 18 2000 585 592
351. V.M. Baragi, R.R. Renkiewicz, H. Jordan, J. Bonadio, J.W. Hartman, and B.J. Roessler Transplantation of transduced chondrocytes protects articular cartilage from interleukin 1-induced extracellular matrix degradation J. Clin. Invest. 96 1995 2454 2460
352. A.L. Carlberg, B. Pucci, R. Rallapalli, R.S. Tuan, and D.J. Hall Efficient chondrogenic differentiation of mesenchymal cells in micromass culture by retroviral gene transfer of BMP-2 Differentiation 67 2001 128 138
353. S.B. Trippel, S.C. Ghivizzani, and A.J. NIXON Gene-based approaches for the repair of articular cartilage Gene Ther. 11 2004 351 359
354. A. Rodriguez, S. Griffiths-Jones, J.L. Ashurst, and A. Bradley Identification of mammalian microRNA host genes and transcription units Genome Res. 14 2004 1902 1910
355. J.-S. Yang, and E.C. Lai Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants Mol. Cell 43 2011 892 903
356. B. Wang, S. Li, H.H. Qi, D. Chowdhury, Y. Shi, and C.D. Novina Distinct passenger strand and mRNA cleavage activities of human Argonaute proteins Nat. Struct. Mol. Biol. 16 2009 1259 1266
357. J.R. Lytle, T.A. Yario, and J.A. Steitz Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR Proc. Natl. Acad. Sci. U. S. A. 104 2007 9667 9672
358. A. McAlinden, N. Varghese, L. Wirthlin, and L.-W. Chang Differentially expressed microRNAs in chondrocytes from distinct regions of developing human cartilage PLoS ONE 8 2013 e75012
359. T. Kobayashi, J. Lu, B.S. Cobb, S.J. Rodda, A.P. McMahon, and E. Schipani et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation Proc. Natl. Acad. Sci. U. S. A. 105 2008 1949 1954
360. S. Miyaki, T. Sato, A. Inoue, S. Otsuki, Y. Ito, and S. Yokoyama et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis Genes Dev. 24 2010 1173 1185
361. K.A. Dudek, J.E. Lafont, A. Martinez-Sanchez, and C.L. Murphy Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes J. Biol. Chem. 285 2010 24381 24387
362. E. Steck, S. Boeuf, J. Gabler, N. Werth, P. Schnatzer, and S. Diederichs et al. Regulation of H19 and its encoded microRNA-675 in osteoarthritis and under anabolic and catabolic in vitro conditions J. Mol. Med. (Berl) 90 2012 1185 1195
363. N. Akhtar, Z. Rasheed, S. Ramamurthy, A.N. Anbazhagan, F.R. Voss, and T.M. Haqqi MicroRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes Arthritis Rheum. 62 2010 1361 1371
364. D. Iliopoulos, K.N. Malizos, P. Oikonomou, and A. Tsezou Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks PLoS ONE 3 2008 e3740
365. K. Yamasaki, T. Nakasa, S. Miyaki, M. Ishikawa, M. Deie, and N. Adachi et al. Expression of MicroRNA-146a in osteoarthritis cartilage Arthritis Rheum. 60 2009 1035 1041
366. S. Miyaki, T. Nakasa, S. Otsuki, S.P. Grogan, R. Higashiyama, and A. Inoue et al. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses Arthritis Rheum. 60 2009 2723 2730
367. G. Tardif, D. Hum, J.-P. Pelletier, N. Duval, and J. Martel-Pelletier Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes BMC Musculoskelet. Disord. 10 2009 148
368. E.A. Lin, L. Kong, X.-H. Bai, Y. Luan, and C.-J. Liu miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1 J. Biol. Chem. 284 2009 11326 11335
369. T.E. Swingler, G. Wheeler, V. Carmont, H.R. Elliott, M.J. Barter, and M. Abu-Elmagd et al. The expression and function of microRNAs in chondrogenesis and osteoarthritis Arthritis Rheum. 64 2012 1909 1919
370. A. Martinez-Sanchez, K.A. Dudek, and C.L. Murphy Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145) J. Biol. Chem. 287 2012 916 924
371. K. Murata, H. Yoshitomi, S. Tanida, M. Ishikawa, K. Nishitani, and H. Ito et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis Arthritis Res. Ther. 12 2010 R86
372. Z.-H. Wang, Z.-Q. Yang, X.-J. He, L. Wang, L.-X. Li, and J.-B. Tu Effects of RNAi-mediated inhibition of aggrecanase-1 and aggrecanase-2 on rat costochondral chondrocytes in vitro Acta Pharmacol. Sin. 29 2008 1215 1226
373. X. Chu, H. You, X. Yuan, W. Zhao, W. Li, and X. Guo Protective effect of lentivirus-mediated siRNA targeting ADAMTS-5 on cartilage degradation in a rat model of osteoarthritis Int. J. Mol. Med. 31 2013 1222 1228
374. K. Nganvongpanit, P. Chaochird, P. Siengdee, P. Pothacharoen, K. Klunklin, and S. Chomdej et al. In vitro suppression of the MMP-3 gene in normal and cytokine-treated human chondrosarcoma using small interfering RNA J. Orthop. Surg. Res. 4 2009 45
375. S. Millington-Ward, H.P. McMahon, D. Allen, G. Tuohy, A.-S. Kiang, and A. Palfi et al. RNAi of COL1A1 in mesenchymal progenitor cells Eur. J. Hum. Genet. 12 2004 864 866
376. Q. Wang, Z. Peng, S. Xiao, S. Geng, J. Yuan, and Z. Li RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin fibroblasts Exp. Dermatol. 16 2007 611 617
377. F. Zhang, Y. Yao, J. Hao, R. Zhou, C. Liu, and Y. Gong et al. A dual-functioning adenoviral vector encoding both transforming growth factor-β3 and shRNA silencing type I collagen: construction and controlled release for chondrogenesis J. Control. Release 142 2010 70 77
378. J.O. Gordeladze, D. Noel, C. Bony, F. Apparailly, P. Louis-Plence, and C. Jorgensen Transient down-regulation of cbfa1/Runx2 by RNA interference in murine C3H10T1/2 mesenchymal stromal cells delays in vitro and in vivo osteogenesis, but does not overtly affect chondrogenesis Exp. Cell Res. 314 2008 1495 1506
379. A. Eguchi, B.R. Meade, Y.-C. Chang, C.T. Fredrickson, K. Willert, and N. Puri et al. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein Nat. Biotechnol. 27 2009 567 571
380. Y. Yao, F. Zhang, R. Zhou, K. Su, J. Fan, and D.-A. Wang Effects of combinational adenoviral vector-mediated TGF beta 3 transgene and shRNA silencing type I collagen on articular chondrogenesis of synovium-derived mesenchymal stem cells Biotechnol. Bioeng. 106 2010 818 828
381. Y. Yao, F. Zhang, P.X. Pang, K. Su, R. Zhou, and Y. Wang et al. In vitro study of chondrocyte redifferentiation with lentiviral vector-mediated transgenic TGF-β3 and shRNA suppressing type I collagen in three-dimensional culture J. Tissue Eng. Regen. Med. 5 2011 e219 e227
382. F. Zhang, Y. Yao, K. Su, P.X. Pang, R. Zhou, and Y. Wang et al. Redifferentiation of dedifferentiated chondrocytes by adenoviral vector-mediated TGF-β3 and collagen-1 silencing shRNA in 3D culture Ann. Biomed. Eng. 39 2011 3042 3054
383. D. Ollitrault, F. Legendre, C. Drougard, M. Briand, H. Bénateau, and D. Goux et al. BMP-2, hypoxia, and COL1A1/HtrA1 siRNAs favor neo-cartilage hyaline matrix formation in chondrocytes: a useful combination for clinical cartilage engineering Tissue Eng. 2014 (submitted for publication)
384. P. Galéra, D. Ollitrault, F. Legendre, M. Demoor, F. Mallein-Gerin, K. Boumédiene et al., Method for obtaining differentiated articular chondrocytes in vitro or ex vivo and uses of them., International Patent WO 2012/ 038668, 08/22/2011.
385. D.B.F. Saris, J. Vanlauwe, J. Victor, M. Haspl, M. Bohnsack, and Y. Fortems et al. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture Am. J. Sports Med. 36 2008 235 246
386. P. Niemeyer, W. Köstler, G.M. Salzmann, P. Lenz, P.C. Kreuz, and N.P. Sudkamp Autologous chondrocyte implantation for treatment of focal cartilage defects in patients age 40 years and older: a matched-pair analysis with 2-year follow-up Am. J. Sports Med. 38 2010 2410 2416
387. J.D. Harris, R.A. Siston, R.H. Brophy, C. Lattermann, J.L. Carey, and D.C. Flanigan Failures, re-operations, and complications after autologous chondrocyte implantation - a systematic review Osteoarthr. Cartil. 19 2011 779 791
388. H.S. Vasiliadis, J. Wasiak, and G. Salanti Autologous chondrocyte implantation for the treatment of cartilage lesions of the knee: a systematic review of randomized studies Knee Surg. Sports Traumatol. Arthrosc. 18 2010 1645 1655
389. P. Vavken, and D. Samartzis Effectiveness of autologous chondrocyte implantation in cartilage repair of the knee: a systematic review of controlled trials Osteoarthr. Cartil. 18 2010 857 863
390. W.B. Robertson, D. Fick, D.J. Wood, J.M. Linklater, M.H. Zheng, and T.R. Ackland MRI and clinical evaluation of collagen-covered autologous chondrocyte implantation (CACI) at two years Knee 14 2007 117 127
391. P. Niemeyer, P. Lenz, P.C. Kreuz, G.M. Salzmann, N.P. Sudkamp, and H. Schmal et al. Chondrocyte-seeded type I/III collagen membrane for autologous chondrocyte transplantation: prospective 2-year results in patients with cartilage defects of the knee joint Arthroscopy 26 2010 1074 1082
392. S. Vijayan, W. Bartlett, G. Bentley, R.W.J. Carrington, J.A. Skinner, and R.C. Pollock et al. Autologous chondrocyte implantation for osteochondral lesions in the knee using a bilayer collagen membrane and bone graft: a two- to eight-year follow-up study J. Bone Joint Surg. (Br.) 94 2012 488 492
393. C.W. McIlwraith, D.D. Frisbie, and C.E. Kawcak The horse as a model of naturally occurring osteoarthritis Bone Joint Res. 1 2012 297 309
394. T. Aigner, J.L. Cook, N. Gerwin, S.S. Glasson, S. Laverty, and C.B. Little et al. Histopathology atlas of animal model systems - overview of guiding principles Osteoarthr. Cartil. 18 2010 S2 S6
395. R. Poole, S. Blake, M. Buschmann, S. Goldring, S. Laverty, and S. Lockwood et al. Recommendations for the use of preclinical models in the study and treatment of osteoarthritis Osteoarthr. Cartil. 2010 S10 S16
396. D. Barnewitz, M. Endres, I. Krüger, A. Becker, J. Zimmermann, and I. Wilke et al. Treatment of articular cartilage defects in horses with polymer-based cartilage tissue engineering grafts Biomaterials 27 2006 2882 2889
397. A.J. Nixon, L. Begum, H.O. Mohammed, B. Huibregtse, M.M. O'Callaghan, and G.L. Matthews Autologous chondrocyte implantation drives early chondrogenesis and organized repair in extensive full- and partial-thickness cartilage defects in an equine model J. Orthop. Res. 29 2011 1121 1130
398. D.D. Frisbie, Y. Lu, C.E. Kawcak, E.F. DiCarlo, F. Binette, and C.W. McIlwraith In vivo evaluation of autologous cartilage fragment-loaded scaffolds implanted into equine articular defects and compared with autologous chondrocyte implantation Am. J. Sports Med. 37 Suppl. 1 2009 71S 80S